Organization: Health Canada
Year: 2024
Month: March
Request Number: A-2023-000908
Request Summary: Adverse Drug Reaction (ADR) for Tecta. Report number: E2B_06483597. ADRs for Mesalazine. Report numbers: E2B_06501204, E2B_06486442, E2B_06479972, E2B_06510119, E2B_06482978, E2B_06479977, E2B_06522595. ADRs for VYVANSE. Report numbers: 001049057, 001051263.
Disposition: Disclosed in part
Number of pages: 129